Canada has long been a global leader in health innovation and science. But a recent review suggests this position is under serious threat. Canada’s science funding structure is in need of serious reform.
The federal government spends more than $10-billion on science and technology annually, but how can we better allocate these resources? What can we do to make research dollars more effective? How do we ensure Canada continues to reap the benefits of clinical trials? Over the years, the funding landscape for R&D has shifted dramatically, so how will Canada continue to attract and retain top research talent?
Gordon McCauley, President and CEO of CDRD joined an iPolitics expert panel which explored the current challenges to health innovation in an attempt to offer solutions to ensure a vibrant life sciences sector that pays economic and health dividends down the road.
Read more about the outcomes of this event: https://ipolitics.ca/2017/05/23/investing-in-health-innovation/